OA10944A - Indoline derivatives useful as 5-ht-2c receptor antagonists - Google Patents

Indoline derivatives useful as 5-ht-2c receptor antagonists Download PDF

Info

Publication number
OA10944A
OA10944A OA9800245A OA9800245A OA10944A OA 10944 A OA10944 A OA 10944A OA 9800245 A OA9800245 A OA 9800245A OA 9800245 A OA9800245 A OA 9800245A OA 10944 A OA10944 A OA 10944A
Authority
OA
OAPI
Prior art keywords
compound according
formula
compound
methyl
methylpyridin
Prior art date
Application number
OA9800245A
Other languages
English (en)
Inventor
Steven Mark Bromidge
Ian Thomson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10944A publication Critical patent/OA10944A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA9800245A 1996-06-20 1998-12-18 Indoline derivatives useful as 5-ht-2c receptor antagonists OA10944A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
OA10944A true OA10944A (en) 2003-02-27

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800245A OA10944A (en) 1996-06-20 1998-12-18 Indoline derivatives useful as 5-ht-2c receptor antagonists

Country Status (33)

Country Link
US (1) US6369060B1 (de)
EP (1) EP0912554B1 (de)
JP (1) JP2000512306A (de)
KR (1) KR20000022045A (de)
CN (1) CN1229408A (de)
AP (2) AP9801410A0 (de)
AR (1) AR008243A1 (de)
AT (1) ATE228514T1 (de)
AU (1) AU718597B2 (de)
BG (1) BG103089A (de)
BR (1) BR9709911A (de)
CA (1) CA2258240A1 (de)
CO (1) CO4890847A1 (de)
CZ (1) CZ420598A3 (de)
DE (1) DE69717449T2 (de)
DZ (1) DZ2250A1 (de)
EA (1) EA001780B1 (de)
ES (1) ES2187783T3 (de)
GB (1) GB9612883D0 (de)
HU (1) HUP9903439A3 (de)
ID (1) ID19433A (de)
IL (1) IL127417A0 (de)
MA (1) MA24214A1 (de)
NO (1) NO985972D0 (de)
NZ (1) NZ333229A (de)
OA (1) OA10944A (de)
PE (1) PE86698A1 (de)
PL (1) PL330796A1 (de)
SK (1) SK282706B6 (de)
TR (1) TR199802661T2 (de)
TW (1) TW382015B (de)
WO (1) WO1997048699A1 (de)
ZA (1) ZA975415B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3030899A (en) * 1998-02-25 1999-09-15 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
MXPA04005151A (es) 2001-11-28 2004-08-11 Upjohn Co Compuestos terapeuticos.
AU2003217817A1 (en) * 2002-03-04 2003-09-22 Pharmacia And Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
CN102348798A (zh) 2009-01-16 2012-02-08 麻省理工学院 孤独症谱系障碍的诊断和治疗
WO2012080497A2 (en) 2010-12-17 2012-06-21 Glaxo Group Limited Methods of treatment and prevention of eye diseases
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
CZ294097B6 (cs) 1995-02-02 2004-10-13 Smithklineábeechamáplc Indolový derivátŹ způsob jeho přípravy a farmaceutická kompozice s jeho obsahem
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
HUP9903439A3 (en) 2002-12-28
NZ333229A (de) 2000-01-28
SK175298A3 (en) 1999-05-07
AP9801410A0 (en) 1998-12-31
CZ420598A3 (cs) 1999-06-16
AP745A (en) 1999-04-28
DZ2250A1 (fr) 2002-12-18
ATE228514T1 (de) 2002-12-15
ID19433A (id) 1998-07-09
SK282706B6 (sk) 2002-11-06
AU718597B2 (en) 2000-04-20
NO985972L (no) 1998-12-18
DE69717449D1 (de) 2003-01-09
BR9709911A (pt) 1999-08-10
WO1997048699A1 (en) 1997-12-24
GB9612883D0 (en) 1996-08-21
AP9701037A0 (en) 1997-07-31
JP2000512306A (ja) 2000-09-19
HUP9903439A2 (en) 2000-07-28
KR20000022045A (ko) 2000-04-25
DE69717449T2 (de) 2003-10-02
NO985972D0 (no) 1998-12-18
MA24214A1 (fr) 1997-12-31
CN1229408A (zh) 1999-09-22
EA199900043A1 (ru) 1999-06-24
EP0912554A1 (de) 1999-05-06
PE86698A1 (es) 1999-01-28
PL330796A1 (en) 1999-06-07
ZA975415B (en) 1998-12-21
EA001780B1 (ru) 2001-08-27
AU3260297A (en) 1998-01-07
ES2187783T3 (es) 2003-06-16
EP0912554B1 (de) 2002-11-27
US6369060B1 (en) 2002-04-09
TR199802661T2 (xx) 1999-03-22
CA2258240A1 (en) 1997-12-24
AR008243A1 (es) 1999-12-29
TW382015B (en) 2000-02-11
IL127417A0 (en) 1999-10-28
BG103089A (en) 1999-09-30
CO4890847A1 (es) 2000-02-28

Similar Documents

Publication Publication Date Title
JP2852659B2 (ja) ピペラジン誘導体およびその塩
US5866586A (en) CNS-active pyridinylurea derivatives
WO1994014801A1 (en) Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
WO2003044016A1 (en) 3-SUBSTITUTED OXINDOLE β3 AGONISTS
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
AU718000B2 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
US6004961A (en) 1,4-disubstituted piperazines
AP745A (en) Heterocyclic compounds and their use in treatment of CNS disorders.
JP2003231633A (ja) 医薬組成物
JPH0699396B2 (ja) 新規オキサゾロピリジン誘導体
EP0984956A1 (de) Indolinderivate als 5ht2c rezeptor antagonisten
JP3643916B2 (ja) 新規な縮合インデン誘導体又はその塩
KR100486795B1 (ko) 5-ht-2c수용체길항제로유용한인돌린유도체
KR20110006173A (ko) 벤조사이오펜 화합물
JP2003055345A (ja) ビフェニルカルボキサミドイソインドリン誘導体、その製法およびその合成中間体